Navigation Links
Daiichi Sankyo, Inc. Awarded Prestigious NCQA Certification for National Under Pressure(TM) Hypertension Management Program

PARSIPPANY, N.J., Dec. 15 /PRNewswire/ -- Daiichi Sankyo, Inc., announced today that Under Pressure(TM), its national hypertension disease management program developed in accordance with JNC-7 guidelines, has received Disease Management Program Design Certification from the National Committee for Quality Assurance (NCQA), a private, not-for-profit organization dedicated to improving health care quality. NCQA certification signifies that the Under Pressure program has passed a rigorous review and successfully meets objective, evidence-based, high standards of health care quality.

"In addition to offering highly effective treatments in cardiovascular care, we are committed to ensuring that consumers have access to high quality, practical tools to help them take the best possible care of their hearts and bodies," said Kevin McDermott, Vice President, Managed Markets, Daiichi Sankyo, Inc. "The Daiichi Sankyo Managed Markets team is honored to represent this widely recognized symbol of quality from the NCQA for our Under Pressure program."

With a focus on improving quality of care, the Under Pressure initiative was launched in 2006 to foster partnerships between leading managed care organizations and the healthcare providers in charge of patient care. The patient is encouraged to be more actively involved in the management of their cardiovascular health by emphasizing the key elements necessary to live with hypertension including diet, exercise and medication. Health plans drive the initiative by inviting appropriate plan members to participate in the campaign. Once patients opt-in, they receive regular educational mailings including an innovative DVD, and are directed to a program Web site featuring articles, which reinforce the educational mailings. Earlier this year, Daiichi Sankyo announced a culturally competent version of the Under Pressure initiative designed for African-Americans with hypertension.

NCQA's certification standards are set high to encourage organizations to continuously enhance program quality. Certification standards are developed with input from researchers in the field; the Disease Management Advisory Council (DMAC) and standing committees; employers; both purchasers and operators of disease management programs; state and federal regulators; and other experts. NCQA has reviewed and certified Daiichi Sankyo's Program Design capability.

Hypertension is one of the most prevalent conditions in the United States affecting approximately one in three American adults (about 73 million people age 20 and older) and approximately one billion people worldwide.(1,2) It is often difficult to control, and of those with high blood pressure, approximately 65 percent do not have the condition under control.(3) The number of people with high blood pressure is expected to reach about 1.6 billion worldwide by 2025.(4)

About Daiichi Sankyo

A global pharma innovator, Daiichi Sankyo Co., Ltd., was established in 2005 through the merger of two leading Japanese pharmaceutical companies. This integration created a more robust organization that allows for continuous development of novel drugs that enrich the quality of life for patients around the world. A central focus of Daiichi Sankyo's research and development are thrombotic disorders, malignant neoplasm, diabetes mellitus, and autoimmune disorders. Equally important to the company are hypertension, hyperlipidemia or atherosclerosis and bacterial infections. For more information, visit

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd. For more information on Daiichi Sankyo, Inc., please visit

(1) American Heart Association. 2004 High Blood Pressure Statistics. Accessed August 27, 2008

(2) Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003;289:2560-2572

(3) American Heart Association. 2004 High Blood Pressure Statistics Site accessed August 28, 2008.

(4) Kearney PM, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-23

    For more information, please contact:

    Alyssa Dargento
    Daiichi Sankyo, Inc.
    Office: 973.630.2913
    Cell: 973.641.1135

SOURCE Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Daiichi Sankyo, Inc. Announces Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology
2. Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
3. Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel
4. Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize
5. Travel Nurse Across America Awarded Certification From The Joint Commission
6. Dr. Ben Berkhout awarded Retrovirology Prize for contribution to HIV research
7. Perot Systems Awarded Contract Extension By Daughters of Charity
8. SpectraScience Awarded U.S. Patent 7,459,696 for its Unique Methods of Calibrating Spectral Data
9. Jefferson researcher awarded NIH grant
10. Perot Systems Awarded Contract to Implement Health Information System in Kingdom of Jordan
11. Biocept Awarded Accreditation by the College of American Pathologists
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
Breaking Medicine Technology: